Grant: Operating Grant: Industry-partnered Collaborative Research
Unity Health Toronto
$500,000.00
The Peritoneal Dialysis Outcomes and Practice Patterns Study (P-DOPPS)
FY 2012-13
Summary
For the 36000 Canadians living with end stage kidney disease, hospital based hemodialysis (HD) is the most common therapy. Less than 20 percent of patients are treated with home based peritoneal dialysis (PD). PD requires a catheter which is inserted in the patient's peritoneum in the abdomen to allow for the removal of fluid and wastes. Compared to HD, PD is associated with similar survival, superior patient satisfaction, and is administered at home by a patient or caregiver at a lower cost. Increasing the use of PD represents an attractive strategy to improve patient outcomes and minimize healthcare costs of dialysis therapy. Yet, over 30 percent of Canadian patients on PD will ultimately require a transfer to HD after 3 years. The transfer to HD may be related to ongoing infection of the PD fluid, complications of the PD catheter, inability of peritoneal membrane to remove the necessary fluid and toxins needed, and difficulty for patients to manage their treatments at home. Across facilities in Canada and between countries, the rates of these treatment related complications vary significantly. This finding may be the result of differences in patient characteristics across facilities. However, it also may relate to the different ways in which PD patients are cared for. The present study will be the Canadian arm of The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) that will be performed in Canada, Japan, UK and USA. PDOPPS will be one of the largest studies following patients on PD. PDOPPS will collect information on the differences in facility practices, and will follow patients over a 3 year period. The study will provide an opportunity to identify different practices in how patients on PD are cared for within 20 representative facilities within Canada comparing these to those facilities in participating countries. This will allow us to identify practices that minimize the need to transfer to HD and improve outcomes for patients on PD.
Department
Program
Operating Grant: Industry-partnered Collaborative Research
Recipient
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
280181
Name
Perl Jeffrey
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Baxter Healthcare Corporation (Deefield, IL)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Industry Partnered Collaborative Research
Projecttitle
The Peritoneal Dialysis Outcomes and Practice Patterns Study (P-DOPPS)
Programtype2
Operating Grants
Orgnameinp2
Unity Health Toronto
Cihramount2
$500,000
Cihrequipment2
$0
Programname2
Operating Grant: Industry-partnered Collaborative Research
Keyworddelim
Collaboration; Hospitalization; Peritoneal Dialysis; Peritoneal Dialysis Treatment Time; Pratice Patterns; Prospective Observational Cohort Study; Quality Of Life; Survival
Abstract
For the 36000 Canadians living with end stage kidney disease, hospital based hemodialysis (HD) is the most common therapy. Less than 20 percent of patients are treated with home based peritoneal dialysis (PD). PD requires a catheter which is inserted in the patient's peritoneum in the abdomen to allow for the removal of fluid and wastes. Compared to HD, PD is associated with similar survival, superior patient satisfaction, and is administered at home by a patient or caregiver at a lower cost. Increasing the use of PD represents an attractive strategy to improve patient outcomes and minimize healthcare costs of dialysis therapy. Yet, over 30 percent of Canadian patients on PD will ultimately require a transfer to HD after 3 years. The transfer to HD may be related to ongoing infection of the PD fluid, complications of the PD catheter, inability of peritoneal membrane to remove the necessary fluid and toxins needed, and difficulty for patients to manage their treatments at home. Across facilities in Canada and between countries, the rates of these treatment related complications vary significantly. This finding may be the result of differences in patient characteristics across facilities. However, it also may relate to the different ways in which PD patients are cared for. The present study will be the Canadian arm of The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) that will be performed in Canada, Japan, UK and USA. PDOPPS will be one of the largest studies following patients on PD. PDOPPS will collect information on the differences in facility practices, and will follow patients over a 3 year period. The study will provide an opportunity to identify different practices in how patients on PD are cared for within 20 representative facilities within Canada comparing these to those facilities in participating countries. This will allow us to identify practices that minimize the need to transfer to HD and improve outcomes for patients on PD.
Competitiondate
201303
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Perl, Jeffrey
Approvedterm
4 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $500,000~ $0~